OSTEO MEND
Natural health product licensed in Canada
- Other names
- Osteo Mend - Advanced Bone Health Formula
- Licence holder
- Vitex Nutrition Ltd.
- NPN or DIN-HM
- 80041358
- Status
- Inactive licence
- Licence date
- 3 April 2013
- Revision date
- Not provided
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Dose déclarée au-delà d'une limite
Magnésium: up to 400 mg a day according to the dosing instructions published by Health Canada (4 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 300 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- À vérifier
Magnésium: up to 400 mg a day according to the dosing instructions published by Health Canada, above the limite de sécurité from EFSAEuropean Food Safety Authority. for adults (250 mg a day). Pour ce nutriment, le repère de l'EFSA ne porte que sur les apports ajoutés (compléments, aliments enrichis), pas sur ce qu'apporte l'alimentation courante.
limite supérieure de sécurité (UL). EFSA, Overview on Tolerable Upper Intake Levels (version 11, August 2025), retrieved 21 October 2026.
- Conditions légales
Medicago sativa L.: L'étiquetage doit comporter un avertissement déconseillant l'usage chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Bambusa vulgaris Source : Shoots - standardized extract Potency : 70 % Silica | 25 mg | Not calculated |
| Magnésium Source : Produit de chélation de magnésium et de protéine végétale hydrolysée (PVH) | 100 mg | 400,000 µg |
| Boron Source : Produit de chélation de bore et de protéine végétale hydrolysée (PVH) | 750 mcg | Not calculated |
| Medicago sativa Source : Sommité | 150 mg | Not calculated |
Non-medicinal ingredients
Croscarmellose sodium, cellulose, Silice, Acide stéarique, Stéarate de magnésium, Carraghénine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 4 Comprimé | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
A factor in the maintenance of good health. Adequate calcium (and vitamin D) (throughout life) as part of a healthy diet, (along with physical activity) may help prevent bone loss/osteoporosis. Helps in the development and maintenance of bones and teeth especially in childhood, adolescence and young adulthood. Adequate calcium (and vitamin D) (throughout life) as part of a healthy diet, (along with physical activity) may reduce the risk of developing osteoporosis. Helps in the development and maintenance of bones and teeth. Helps the body to metabolize carbohydrates, fats and proteins. Helps in tissue formation. Helps to maintain proper muscle function. Helps in the absorption and use of calcium and phosphorus. Calcium intake, when combined with sufficient Vitamin D, a healthy diet and regular exercise may reduce the risk of developing osteoporosis.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80041358
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.